1. Mekhail TM, Markmann M. Acanthosis nigricans with endometrial carcinoma:case report and review of the literature. Gynecol Oncol 2002; 84: 332-34.
2. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989; 87: 269-72.
3. Anderson SHC, Hudson-Peacock M, Muller F. Malignant acanthosis nigricans: Potential role of chemotherapy. Br J Dermatol 1999; 144: 714-16.
4. Yeh JSM, Munn SE, Plunkett TA, et al. Coexistence of acanthosis nigricans and the sign of Leser-Trélat in a patient with gastric adenocarcinoma: A case report and literature review. J Am Acad Dermatol 2000; 42: 357-62.
5. Aydemir E, Aydemir İ, Oğuz O ve ark. Mide kanseriyle birlikte olan bir malign acanthosis nigricans olgusu. Türkderm Deri Hast ve Frengi Arşivi, 1996, 30: 103-4.
6. Smeena S, William J, Lynn S. Cutaneous manifestations of cancer. Current Opinion in Oncol 1999; 11: 139-50.
7. Boyce S, Harper J. Paraneoplastic dermatoses. Dermatol Clin 2002; 20: 523-32.
8. Longshore SJ, Taylor JS, Kennedy A, Nurko S. Malignant acanthosis nigricans and endometroid adenocarcinoma of the parametrium: the search for malignancy. J Am Acad Dermatol 2003; 49: 541-43.
9. Pentenero M, Carrozzo M, Pagano M, Gandolfo S. Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol 2004; 43: 530-2.
10. Koyama S, Ikeda K, Sato M, et al. Transforming growth factor alpha-producing gastric carcinoma with acanthosis nigricans: An endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroentero 1997; 32: 71-77.
